• LY2886721: BACE Inhibitor Workflows for Alzheimer's Research

  2026-06-17

  LY2886721, a potent oral BACE1 inhibitor, delivers reproducible amyloid beta reduction and precise modulation of APP processing in Alzheimer's disease models. This guide translates cutting-edge findings and real lab experiences into actionable protocols and troubleshooting strategies for advanced BACE1 enzyme inhibition studies.

• Cy5-UTP: Precision RNA Labeling for FISH and Expression Arra

  2026-06-17

  Cy5-UTP (Cyanine 5-uridine triphosphate) elevates fluorescent RNA labeling for highly sensitive, direct detection in FISH, dual-color arrays, and advanced phase separation analyses. Discover robust protocol enhancements, troubleshooting strategies, and practical tips to streamline your RNA probe workflows using APExBIO's trusted reagent.

• 10074-G5: Advancing c-Myc Inhibitor Workflows in Cancer Rese

  2026-06-16

  10074-G5 offers robust, selective disruption of c-Myc/Max dimerization, enabling precise studies of apoptosis, cell cycle arrest, and tumor regression. This guide translates cutting-edge research into actionable protocols and troubleshooting strategies for maximizing performance in cancer research assays.

• E-64d: Applied Workflows for Calpain Inhibition and Cell Dea

  2026-06-16

  E-64d empowers precise inhibition of intracellular cysteine proteases, making it indispensable for dissecting regulated cell death in both neuroscience and oncology research. This article unpacks actionable workflows, evidence-led protocol tips, and troubleshooting strategies to harness E-64d’s unique properties for robust experimental outcomes.

• Tariquidar (XR9576): Applied Protocols for Drug Resistance R

  2026-06-15

  Tariquidar (XR9576) empowers researchers to dissect P-glycoprotein-mediated chemoresistance, even in challenging high-viscosity tumor microenvironments. This guide delivers actionable protocol enhancements, advanced applications, and troubleshooting strategies—anchored in recent mechanobiology discoveries—for reliable ABC transporter inhibition in drug resistance research.

• Optimizing mRNA Delivery with EZ Cap Cy5 Firefly Luciferase

  2026-06-15

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) from APExBIO merges dual-mode bioluminescence and fluorescence for robust mRNA delivery and intracellular tracking. Its Cap1 capping, 5-moUTP modification, and Cy5 labeling enable researchers to troubleshoot, optimize, and quantify translation efficiency with unmatched sensitivity.

• MAPK10 Phosphorylation of KRT16 Suppresses NSCLC Metastasis

  2026-06-14

  This study establishes that MAPK10 directly phosphorylates keratin 16 (KRT16) in non-small cell lung cancer (NSCLC), leading to its ubiquitination and proteasomal degradation. These findings identify the MAPK10/KRT16/RNF213 axis as a mechanistic link in metastatic suppression and suggest new avenues for prognostic and therapeutic development in NSCLC.

• HyperScribe™ SP6 Kit: Precision RNA Synthesis for Innate Imm

  2026-06-13

  Explore the HyperScribe SP6 High Yield RNA Synthesis Kit for advanced RNA production, with a unique focus on innate immune pathway studies and translational virology. Discover how this SP6 RNA polymerase kit empowers cutting-edge research beyond standard workflows.

• Sisomicin (BA1199): Reliable Solutions for Antibacterial Ass

  2026-06-12

  This article addresses practical laboratory challenges in Gram-positive and Gram-negative bacterial infection research, focusing on the use of Sisomicin (SKU BA1199) for reproducible in vitro antibacterial testing. Scenario-driven Q&A blocks provide evidence-based insights for biomedical researchers, highlighting how Sisomicin supports assay optimization and data reliability.

• Proteolytic Neuroligin 1 Fragments Sustain Social Memory Cir

  2026-06-12

  Liu et al. identify that proteolytic fragments of neuroligin 1, generated via social interaction-induced α- and γ-secretase activity in the ventral hippocampus, are essential for maintaining short-term social memory in mice. This mechanistic insight connects extracellular cleavage to intracellular signaling and synaptic plasticity, offering a new perspective on memory maintenance and its potential disruption in neuropsychiatric disorders.

• BMS-345541 Hydrochloride: Precision IKK Inhibition in Cell D

  2026-06-11

  Explore how BMS-345541 hydrochloride, a selective IKK inhibitor, advances inflammation and cancer biology research by enabling precise dissection of apoptosis and necroptosis. This article uniquely examines the interplay between IKK inhibition and RIPK1-regulated cell death, offering actionable insights for NF-κB pathway studies.

• Flumequine in Translational Cancer Research: Mechanisms and

  2026-06-11

  This article explores Flumequine, a potent DNA topoisomerase II inhibitor, as a strategic asset for translational researchers. Merging mechanistic insight with practical assay guidance, we discuss how Flumequine advances experimental precision in DNA replication studies, the evolving landscape of in vitro drug response metrics, and future-oriented recommendations for leveraging this compound in cancer biology and antibiotic resistance research.

• Silybin A in Silymarin: Hepatoprotective Innovation for Live

  2026-06-10

  Silybin A, a principal component of Silymarin, delivers unparalleled reproducibility and pathway specificity for advanced liver disease and metabolic enzyme research. This article decodes practical workflows, protocol optimization, and troubleshooting tips—translating cutting-edge chemistry into streamlined bench success.

• Imipenem in Antibacterial Research: Protocols and Innovation

  2026-06-10

  Imipenem, a semisynthetic thienamycin antibiotic, stands out for its robust performance against multidrug-resistant bacteria and its unique immune-modulatory effects in research models. This guide walks through optimized workflow integrations, troubleshooting, and experimental design choices that leverage APExBIO's Imipenem for breakthrough results in antibacterial and immune response research.

• Flavone Glucosides from Scutellaria baicalensis: Structural

  2026-06-09

  The reference study systematically identified and characterized two novel flavone 2'-glucosides and several known phenolics, including baicalin and baicalin methyl ester, from Scutellaria baicalensis roots. This foundational phytochemical work underpins ongoing research into the anti-inflammatory and barrier-protective properties of these compounds, especially in the context of LPS-induced intestinal barrier damage models.

446 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page